Evidence map›Paper›PMID 40047645›Full record

ArticleMolecular cancer research : MCR2025

Insulin Resistance Increases TNBC Aggressiveness and Brain Metastasis via Adipocyte-Derived Exosomes.

Yuhan Qiu, Andrew Chen, Rebecca Yu, Pablo Llevenes, Michael Seen, Naomi Y Ko, Stefano Monti, Gerald V Denis

Abstract read
In one paragraph

Article in Molecular cancer research : MCR, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Biological profile of breast cancer brain metastasis.Acta neuropathologica communications · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Yuhan QiuCancer Center, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts.ORCID 0000-0003-3770-7977
Andrew ChenDepartment of Medicine, Computational Biomedicine Section, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts.ORCID 0000-0002-8508-0227
Rebecca YuCancer Center, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts.ORCID 0000-0002-4137-7993
Pablo LlevenesCancer Center, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts.ORCID 0000-0003-1925-7204
Michael SeenCancer Center, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts.ORCID 0009-0008-7823-1526
Naomi Y KoSection of Hematology Oncology, Boston Medical Center, Boston, Massachusetts.ORCID 0000-0001-9689-9601
Stefano MontiDepartment of Medicine, Computational Biomedicine Section, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts.ORCID 0000-0002-9376-0660
Gerald V DenisCancer Center, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts.ORCID 0000-0001-9886-0401

Funding

Mechanisms of BET bromodomain metabolic reprogramming in triple negative breast cancerR01CA222170 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI DENIS, GERALD V · 2018 to 2022
$3.1M
Uncoupling obesity from breast cancer in African American womenU01CA182898 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI DENIS, GERALD V, PALMER, JULIE R · 2013 to 2017
$3.1M
Multiscale analysis of metabolic inflammation as a driver of breast cancerU01CA243004 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI DENIS, GERALD V, EMILI, ANDREW · 2020 to 2024
$2.8M
National Cancer Institute (NCI) R01CA222170National Cancer Institute (NCI) U01CA182898National Cancer Institute (NCI) U01CA243004NCI NIH HHS R01 CA222170NCI NIH HHS U01 CA182898NCI NIH HHS U01 CA243004
6 · The paper itself

Abstract

Patients with triple-negative breast cancer (TNBC) and comorbid type 2 diabetes (T2D), characterized by insulin resistance of adipose tissue, have a higher risk of metastasis and shorter survival. Adipocytes are the main nonmalignant cells of the breast tumor microenvironment (TME). However, adipocyte metabolism is usually ignored in oncology, and the mechanisms that couple T2D to TNBC outcomes are poorly understood. In this study, we hypothesized that exosomes, small vesicles secreted by TME breast adipocytes, drive epithelial-to-mesenchymal transition (EMT) and metastasis in TNBC via miRNAs. Exosomes were purified from conditioned media of 3T3-L1 mature adipocytes, either insulin-sensitive (IS) or insulin-resistant (IR). Murine 4T1 cells, a TNBC model, were treated with exosomes in vitro (72 hours). EMT, proliferation, and angiogenesis were elevated in IR versus control and IS. Brain metastases showed more mesenchymal morphology and EMT enrichment in the IR group. MiR-145a-3p is highly differentially expressed between IS and IR and potentially regulates metastasis. IMPLICATIONS: IR adipocyte exosomes modify the TME, enhance EMT, and promote brain metastasis-likely via miRNA pathways-suggesting that metabolic diseases such as T2D foster a prometastatic TME, reducing survival and warranting close monitoring and potential metabolic interventions in patients with TNBC and T2D.

Indexed as

AdipocytesBrain NeoplasmsExosomesInsulin ResistanceTriple Negative Breast Neoplasms3T3-L1 CellsAnimalsCell Line, TumorCell ProliferationEpithelial-Mesenchymal TransitionFemaleHumansMiceMicroRNAsNeoplasm MetastasisTumor MicroenvironmentMicroRNAs

Identifiers

PMID40047645
PMCPMC12133429

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.